UK markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.28+0.79 (+4.79%)
As of 01:51PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
78,637
105,762
181,564
114,634
Total cash
78,637
105,762
181,564
114,634
Net receivables
22,454
12,531
7,712
0
Inventory
5,065
6,702
5,512
0
Other current assets
4,955
5,452
7,473
7,729
Total current assets
111,111
130,447
202,261
122,363
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,636
2,343
5,689
6,394
Net property, plant and equipment
1,636
2,343
5,689
6,394
Intangible assets
-
2,986
1,663
-
Other long-term assets
12,491
5,680
3,170
3,290
Total non-current assets
16,758
11,009
10,522
9,684
Total assets
127,869
141,456
212,783
132,047
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,060
14,175
13,552
9,372
Accrued liabilities
9,308
10,796
10,663
5,594
Total current liabilities
20,128
28,284
27,875
19,535
Non-current liabilities
Other long-term liabilities
864
802
851
1,968
Total non-current liabilities
6,756
3,951
4,802
6,676
Total liabilities
26,884
32,235
32,677
26,211
Stockholders' equity
Common stock
4
4
4
4
Retained earnings
-457,470
-436,043
-340,475
-285,200
Accumulated other comprehensive income
449
1,331
1,371
-526
Total stockholders' equity
100,985
109,221
180,106
105,836
Total liabilities and stockholders' equity
127,869
141,456
212,783
132,047